MedPath

EMG evaluation of the Pelvic Floor and Functional Outcomes in patients who underwent Rectal Cancer Treatment

Conditions
Patients after Low anterior resection and/or (chemo)radition
Registration Number
NL-OMON23744
Lead Sponsor
Internal sponsorship of the LUMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
46
Inclusion Criteria

To be eligible to participate in this study, a subject must meet all the following criteria:
- The patient underwent treatment for rectal cancer by LAR, LAR preceded by SCRT, LAR preceded by CRT or CRT alone in the period January 2015 till December 2017.
- > 18 years of age.
- Proficiency of the Dutch language.
- Able and willing to read and fill in questionnaires.
- Written informed consent.

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients who underwent abdomino- perineal resection (APR) or Hartman resection.
- Patients with a diverting colostoma.
- Neurological comorbidity (spinal lesion or cerebrovascular accident (CVA)) or muscle disease (Multiple Sclerosis (MS)).
- Patients who deceased
- Patients with a local relapse
- Patients with metastasis in a distant organ

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the correlation between EMG values of the pelvic floor and functional outcomes of patients who has been treated for rectal cancer in the period January 2015 till December 2017.<br>
Secondary Outcome Measures
NameTimeMethod
1) To compare EMG values of the pelvic floor after rectal cancer treatment between different treatment groups (LAR, LAR preceded by Short Course Radiotherapy (SCRT), LAR preceded by chemoradiotherapy (CRT), or CRT alone).<br>- 2) To compare functional outcome after rectal cancer treatment between different treatment groups (LAR, LAR preceded by Short Course Radiotherapy (SCRT), LAR preceded by chemoradiotherapy (CRT), or CRT alone).<br>- 3) To determine a correlation between EMG values of the pelvic floor after (chemo)radiotherapy of the rectum and the radiation dose to the different individual muscles of the pelvic floor.<br>Stu<br>
© Copyright 2025. All Rights Reserved by MedPath